Pyrazolopyrimidine derivatives as cyclin-dependant kinase inhibitors

This book contains both review and synthesis of new pyrazolo[3,4-d]pyrimidine derivatives as cycline dependent kinase inhibitors (CDKIs). Moreover, cytotoxic activity for the newly synthesized compounds were evaluated, specially on breast cancer cell line (MCF-7). The results obtained were compared with methotrexate as a reference drug. Docking study and molecular modeling were also done using MOE program. I hope this work to be helpful and a starting point for much more new compounds with better activity to help in treatment of such a big terrible disease like cancer. Author: Phoebe F. Lamie

Autorentext

I'm a Lecturer of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni Suef University,Egypt.I was born in Beni Suef city, Egypt in 1981.I completed my studies as a pharmacist in 2003.I was a demonstrator and then assistant lecturer in the Faculty of Pharmacy, Beni Suef University,Egypt from 2004-2013.Since Feb. 2013,I'm a lecturer.